{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:01:48Z","timestamp":1772611308669,"version":"3.50.1"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"DOI":"10.3389\/fncel.2020.00034","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T04:26:01Z","timestamp":1582086361000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review"],"prefix":"10.3389","volume":"14","author":[{"given":"Miriam","family":"Mecha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Carrillo-Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Feli\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyre","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Guaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.06.017","article-title":"Synaptic functions of endocannabinoid signaling in health and disease","volume":"124","author":"Araque","year":"2017","journal-title":"Neuropharmacology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1523\/JNEUROSCI.23-07-02511.2003","article-title":"Therapeutic action of cannabinoids in a murine model of multiple sclerosis","volume":"23","author":"Ar\u00e9valo-Mart\u00edn","year":"2003","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nn.3053","article-title":"Mitochondrial CB1 receptors regulate neuronal energy metabolism","volume":"15","author":"B\u00e9nard","year":"2012","journal-title":"Nat. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1523\/JNEUROSCI.4814-06.2007","article-title":"Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis","volume":"27","author":"Benito","year":"2007","journal-title":"J. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/glia.22742","article-title":"Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo","volume":"63","author":"Bernal-Chico","year":"2015","journal-title":"Glia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-3-319-20825-1_6","article-title":"Endocannabinoids and the immune system in health and disease","volume":"231","author":"Cabral","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nbd.2005.03.002","article-title":"Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and\/or vanilloid receptors in a rat model of multiple sclerosis","volume":"20","author":"Cabranes","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1093\/brain\/awm160","article-title":"The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis","volume":"130","author":"Centonze","year":"2007","journal-title":"Brain"},{"key":"B9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pneurobio.2017.10.007","article-title":"The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for other neuroinflammatory diseases","volume":"160","author":"Chiurchi\u00f9","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/glia.20907","article-title":"Anandamide enhances IL-10 production in activated microglia by targeting CB2 receptors: roles of ERK1\/2, JNK, and NF-\u03baB","volume":"58","author":"Correa","year":"2010","journal-title":"Glia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1172\/jci200317652","article-title":"Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212","volume":"111","author":"Croxford","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuron.2018.09.022","article-title":"The meningeal lymphatic system: a new player in neurophysiology","volume":"100","author":"Da Mesquita","year":"2018","journal-title":"Neuron"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1136\/jnnp.2007.139071","article-title":"Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis","volume":"79","author":"Di Filippo","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B15","first-page":"44","article-title":"On oxycannabin from Indian hump","volume":"14","author":"Dunstan","year":"1989","journal-title":"Proc. Chem. Soc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8385","DOI":"10.1523\/JNEUROSCI.2900-16.2017","article-title":"2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination","volume":"37","author":"Feli\u00fa","year":"2017","journal-title":"J. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1111\/bph.13159","article-title":"A Sativex\u00ae -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis","volume":"172","author":"Feli\u00fa","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1203\/pdr.0b013e318123fbb8","article-title":"The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats","volume":"62","author":"Fern\u00e1ndez-L\u00f3pez","year":"2007","journal-title":"Pediatr. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/s1474-4422(19)30032-8","article-title":"Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders","volume":"18","author":"Friedman","year":"2019","journal-title":"Lancet Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid \u03949-THCV in animal models of Parkinson\u2019s disease","volume":"163","author":"Garc\u00eda","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molbrainres.2004.08.025","article-title":"Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors","volume":"132","author":"Golech","year":"2004","journal-title":"Mol. Brain Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11481-015-9609-x","article-title":"A basal tone of 2-arachidonoylglycerol contributes to early oligodendrocyte progenitor proliferation by activating phosphatidylinositol 3-kinase (PI3K)\/AKT and the mammalian target of rapamycin (MTOR) pathways","volume":"10","author":"Gomez","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/bph.13368","article-title":"Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPAR\u03b3 and 5-HT1A receptors","volume":"173","author":"Hind","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jns.2009.07.021","article-title":"Plasma endocannabinoid levels in multiple sclerosis","volume":"287","author":"Jean-Gilles","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/bc.bc_29_18","article-title":"The endocannabinoid system and stroke: a focused review","volume":"5","author":"Kolb","year":"2019","journal-title":"Brain Circ."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL\/6 mice","volume":"163","author":"Kozela","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/0269881110367732","article-title":"Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis","volume":"25","author":"Lanciego","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.clim.2006.11.002","article-title":"CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents","volume":"122","author":"Lombard","year":"2007","journal-title":"Clin. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1460-9568.2008.06377.x","article-title":"Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide","volume":"28","author":"Lor\u00eda","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrn3846","article-title":"Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies","volume":"15","author":"Maccarrone","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/17512433.2017.1292849","article-title":"Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?","volume":"10","author":"Maccarrone","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bcp.2018.07.042","article-title":"Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination","volume":"157","author":"Manterola","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","article-title":"Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli","volume":"95","author":"Maresz","year":"2005","journal-title":"J. Neurochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Mart\u00edn-Moreno","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: therapeutic implications","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/glia.23317","article-title":"2-AG limits Theiler\u2019s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs","volume":"66","author":"Mecha","year":"2018","journal-title":"Glia"},{"key":"B42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-d","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0180651","DOI":"10.1371\/journal.pone.0180651","article-title":"Sativex in resistant multiple sclerosis spasticity: discontinuation study in a large population of Italian patients (SA.FE. study)","volume":"12","author":"Messina","year":"2017","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.bcp.2006.06.037","article-title":"The synthetic cannabinoid WIN 55,212\u20132 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler\u2019s virus infection","volume":"72","author":"Mestre","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.mcn.2008.10.015","article-title":"A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules","volume":"40","author":"Mestre","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1742-2094-8-102","article-title":"Anandamide inhibits Theiler\u2019s virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors","volume":"8","author":"Mestre","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/sj.bjp.0707523","article-title":"CB2 receptor-mediated migration of immune cells: it can go either way","volume":"153","author":"Miller","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-319-45541-9_4","article-title":"Molecular targets of the phytocannabinoids: a complex picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2174\/092986710790980069","article-title":"GPR55: current knowledge and future perspectives of a purported \u201cType-3\u201d cannabinoid receptor","volume":"17","author":"Moriconi","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1191\/1352458504ms1009oa","article-title":"Win 55212\u20132, a cannabinoid receptor agonist, attenuates leukocyte\/endothelial interactions in an experimental autoimmune encephalomyelitis model","volume":"10","author":"Ni","year":"2004","journal-title":"Mult. Scler."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1096\/fj.04-2464fje","article-title":"Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis","volume":"19","author":"Ortega-Guti\u00e9rrez","year":"2005","journal-title":"FASEB J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nn.3161","article-title":"Immune surveillance in the central nervous system","volume":"15","author":"Ousman","year":"2012","journal-title":"Nat. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.1074\/jbc.m707960200","article-title":"The CB2 cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis","volume":"283","author":"Palazuelos","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"413S","DOI":"10.1002\/j.1552-4604.1981.tb02621.x","article-title":"Treatment of human spasticity with \u0394 9-tetrahydrocannabinol","volume":"21","author":"Petro","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.2174\/092986710790980014","article-title":"From surface to nuclear receptors: the endocannabinoid family extends its assets","volume":"17","author":"Pistis","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4628-11.2012","article-title":"Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions","volume":"32","author":"Ramirez","year":"2012","journal-title":"J. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0165-5728(99)00082-x","article-title":"Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines","volume":"98","author":"Ransohoff","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/jir.2013.0158","article-title":"How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms","volume":"34","author":"Reder","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.imbio.2009.04.001","article-title":"Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression","volume":"215","author":"Rieder","year":"2010","journal-title":"Immunobiology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bcp.2018.07.049","article-title":"Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis","volume":"157","author":"Rodr\u00edguez-Cueto","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.imbio.2010.03.009","article-title":"Cannabis-based medicines in multiple sclerosis\u2014a review of clinical studies","volume":"215","author":"Rog","year":"2010","journal-title":"Immunobiology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-3-319-54564-6_2","article-title":"History of cannabis as medicine: nineteenth century irish physicians and correlations of their observations to modern research","volume-title":"Cannabis Sativa L.: Botany and Biotechnology","author":"Russo","year":"2017"},{"key":"B65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnint.2018.00051","article-title":"Cannabis therapeutics and the future of neurology","volume":"12","author":"Russo","year":"2018","journal-title":"Front. Integr. Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clim.2011.02.010","article-title":"Neuroprotective agents: cannabinoids","volume":"142","author":"S\u00e1nchez","year":"2012","journal-title":"Clin. Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.brainresbull.2009.01.011","article-title":"Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans","volume":"79","author":"Schley","year":"2009","journal-title":"Brain Res. Bull."},{"key":"B68","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1007\/s12035-019-1637-8","article-title":"Efficacy of cannabinoids in a pre-clinical drug-screening platform for Alzheimer\u2019s disease","volume":"56","author":"Schubert","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"key":"B70","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1191\/0269215503cr581oa","article-title":"A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms","volume":"17","author":"Wade","year":"2003","journal-title":"Clin. Rehabil."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.2174\/156802611796904843","article-title":"TRPV1 signaling: mechanistic understanding and therapeutic potential","volume":"11","author":"Xia","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1046\/j.1365-2567.1998.00639.x","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo","volume":"160","author":"Yanagawa","year":"1998","journal-title":"J. Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/s1474-4422(13)70159-5","article-title":"Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial","volume":"12","author":"Zajicek","year":"2013","journal-title":"Lancet Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1136\/jnnp.2005.070136","article-title":"Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up","volume":"76","author":"Zajicek","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B76","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/strokeaha.111.631044","article-title":"Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage\/microglial activation concomitant to neuroprotection","volume":"43","author":"Zarruk","year":"2012","journal-title":"Stroke"},{"key":"B77","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s0074-7742(07)79024-4","article-title":"Glatiramer acetate: mechanisms of action in multiple sclerosis","volume":"79","author":"Ziemssen","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"E833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fncel.2020.00034\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T04:26:03Z","timestamp":1582086363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fncel.2020.00034\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":79,"alternative-id":["10.3389\/fncel.2020.00034"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2020.00034","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"article-number":"34"}}